亚洲精品国产v片在线观看,欧美v日韩v国产综合,亚洲av片一区二区三区不卡不,日韩欧美中文在线播放

行業(yè)產(chǎn)品

  • 行業(yè)產(chǎn)品

上海瑞齊生物科技有限公司


當(dāng)前位置:上海瑞齊生物科技有限公司>>一抗>>Anti-Acetyl-Histone H4 (Lys8)乙?;M蛋白H4抗體

Anti-Acetyl-Histone H4 (Lys8)乙?;M蛋白H4抗體

返回列表頁(yè)
參  考  價(jià)面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品       牌

廠商性質(zhì)生產(chǎn)商

所  在  地上海

聯(lián)系方式:楊經(jīng)理查看聯(lián)系方式

更新時(shí)間:2017-09-13 12:14:30瀏覽次數(shù):288次

聯(lián)系我時(shí),請(qǐng)告知來(lái)自 環(huán)保在線

經(jīng)營(yíng)模式:生產(chǎn)廠家

商鋪產(chǎn)品:88條

所在地區(qū):上海上海

聯(lián)系人:楊經(jīng)理

產(chǎn)品簡(jiǎn)介

Anti-Acetyl-Histone H4 (Lys8)乙?;M蛋白H4抗體

詳細(xì)介紹

Anti-Acetyl-Histone H4 (Lys8)乙?;M蛋白H4抗體

專(zhuān)業(yè)提供Anti-Acetyl-Histone H4 (Lys8)乙?;M蛋白H4抗體,廣泛應(yīng)用于免疫組化,ELISA,Western Blot  IHC-F(免疫組化-冰凍切片),IHC-P (免疫組化-石蠟切片)IP(免疫沉淀), Flow-Cyt等方面。 

產(chǎn)品編號(hào)  Rs-3747R
英文名稱(chēng)  Anti-Acetyl-Histone H4 (Lys8)
中文名稱(chēng)  乙?;M蛋白H4抗體

別    名  H4F2; H4FN; HIST1H4; HIST2H4; HISTH4H4; methyl histone H4; methylated histone H4. 
抗體介紹:Histone proteins H3, H4, H2A, and H2B function as building blocks to package eukaryotic DNA into repeating nucleosome units that are folded in higher order chromatin fibers. The nucleosome is composed of an octamer containing a H3/H4 tetramer and two H2A/H2B dimers, surrounded by approximay 146 base pairs of DNA. A diverse and elaborate array of post-translational modifications including acetylation, phosphorylation, methylation, ubiquitination, and ADP-ribosylation occurs on the N-terminal tail domains of histones. Methylation of position-specific lysine residues in histone N termini is a central modification for regulating epigenetic transitions in chromatin. Each methylatable lysine residue can exist in a mono, di, or tri methylated state. Arginine resdiues can also by mono or di methylated.
產(chǎn)品類(lèi)型  一抗 乙?;贵w 
抗體來(lái)源  Rabbit 
克隆號(hào)  Polyclonal
交叉反應(yīng)  hu, rat, mo
性狀  Lyophilized or Liquid
濃度  1mg/1ml
免疫原  KLH conjugated synthetic peptide derived from hu Acetyl-Histone H4 (Lys8).
亞型  IgG
純化方法  affinity purified by Protein A
儲(chǔ)存液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用  WB=1:100-500 Elisa=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1/20-1/100
(石蠟切片需做抗原修復(fù))Not yet tested in other applications.
 Optimal dilutions/concentrations should be determined by the end user. 
研究領(lǐng)域  細(xì)胞生物 免疫學(xué) 染色質(zhì)和核信號(hào) 轉(zhuǎn)錄調(diào)節(jié)因子 
保存  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

公司提供的.已被國(guó)內(nèi)外廣大科研工作者使用,廣泛用于分子生物學(xué)、免疫學(xué)等試驗(yàn)中。

相關(guān)產(chǎn)品:
Anti-CCR-8(C-C chemokine receptor 8)   細(xì)胞表面趨化因子受體8抗體
Anti-CCL25/CCR-9(C-C chemokine receptor 9)   細(xì)胞表面趨化因子受體9抗體
Anti-CCL28/MEC(C-C motif chemokine 28)   粘膜相關(guān)上皮趨化因子28抗體
Anti-CCR-10(C-C chemokine receptor 10)   細(xì)胞表面趨化因子受體10抗體
Anti-CCRK(Cell cycle related kinase)   細(xì)胞周期相關(guān)激酶抗體
Anti-CD10/CALLA (Neutral Endopeptidase)   CD10抗體
Anti-CD105/Endoglin/TGF-β receptor   CD105/轉(zhuǎn)化生長(zhǎng)因子β受體抗體
Anti-CD117/c-kit/SCFR   干細(xì)胞生長(zhǎng)因子受體/細(xì)胞表面分化抗原抗體
Anti-phospho-c-kit/SCFR/CD117(pTyr936)   抗磷酸化原癌基因c-kit抗體
Anti-CD133 antigen   造血干細(xì)胞抗原CD133抗體


感興趣的產(chǎn)品PRODUCTS YOU ARE INTERESTED IN

環(huán)保在線 設(shè)計(jì)制作,未經(jīng)允許翻錄必究 .? ? ? Copyright(C)?2021 http://www.zuisujiong.cn,All rights reserved.

以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),環(huán)保在線對(duì)此不承擔(dān)任何保證責(zé)任。 溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

請(qǐng) 登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |